SGX:A50

Stock Analysis Report

Thomson Medical Group

Executive Summary

Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore, Malaysia, the United Kingdom, China, the Middle East, and internationally.

Snowflake

Fundamentals

Moderate growth potential with weak fundamentals.


Similar Companies

Share Price & News

How has Thomson Medical Group's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

3.5%

A50

0.9%

SG Healthcare

0.9%

SG Market


1 Year Return

-28.0%

A50

-11.4%

SG Healthcare

1.4%

SG Market

Return vs Industry: A50 underperformed the SG Healthcare industry which returned -11.4% over the past year.

Return vs Market: A50 underperformed the SG Market which returned 1.4% over the past year.


Shareholder returns

A50IndustryMarket
7 Day3.5%0.9%0.9%
30 Day-3.3%0.8%-2.3%
90 Day-9.2%-4.3%-6.7%
1 Year-27.8%-28.0%-9.9%-11.4%5.4%1.4%
3 Yearn/a-20.1%-25.0%15.8%3.4%
5 Yearn/a-14.7%-23.6%11.3%-7.0%

Price Volatility Vs. Market

How volatile is Thomson Medical Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Thomson Medical Group undervalued compared to its fair value and its price relative to the market?

211.47x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Undervalued: A50 (SGD0.06) is trading above our estimate of fair value (SGD0.02)

Significantly Undervalued: A50 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: A50 is poor value based on its PE Ratio (211.5x) compared to the Healthcare industry average (27.1x).

PE vs Market: A50 is poor value based on its PE Ratio (211.5x) compared to the SG market (13.4x).


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate A50's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: A50 is overvalued based on its PB Ratio (2.7x) compared to the SG Healthcare industry average (2.3x).


Next Steps

Future Growth

How is Thomson Medical Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

32.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: A50's forecast earnings growth (32.6% per year) is above the savings rate (2.3%).

Earnings vs Market: A50's earnings (32.6% per year) are forecast to grow faster than the SG market (5.7% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A50's revenue is forecast to grow faster than the SG market.

High Growth Revenue: Insufficient data to determine if A50's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: Insufficient data to determine if A50's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Thomson Medical Group performed over the past 5 years?

-34.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: A50's earnings have declined by -34.7% per year over the past 5 years.

Accelerating Growth: A50's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: A50 had negative earnings growth (-46.8%) over the past year, making it difficult to compare to the Healthcare industry average (-13.3%).


Return on Equity

High ROE: A50's Return on Equity (1.8%) is considered low.


Return on Assets

ROA vs Industry: A50's Return on Assets is below or equal to the Healthcare industry average last year.


Return on Capital Employed

ROCE Improving: A50's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is Thomson Medical Group's financial position?


Financial Position Analysis

Short Term Liabilities: A50's short term assets (SGD292.3M) do not cover its short term liabilities (SGD298.0M)

Long Term Liabilities: A50's short term assets (292.3M) do not cover its long term liabilities (360.9M)


Debt to Equity History and Analysis

Debt Level: A50's debt to equity ratio (87.5%) is considered high

Reducing Debt: Insufficient data to determine if A50's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: A50's debt is not well covered by operating cash flow (8.5%).

Interest Coverage: A50's interest payments on its debt are not well covered by EBIT (1.9x coverage).


Balance Sheet

Inventory Level: A50 has a high level of physical assets or inventory.

Debt Coverage by Assets: A50's debt is not covered by short term assets (assets are 0.5x debt).


Next Steps

Dividend

What is Thomson Medical Group's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.5%markettop25%5.6%industryaverage2.9%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate A50's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate A50's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if A50's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A50's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of A50's dividend in 3 years as they are not forecast to pay a notable one for the SG market.


Next Steps

Management

What is the CEO of Thomson Medical Group's salary, the management and board of directors tenure and is there insider trading?

0.8yrs

Average management tenure


CEO

Thomson Medical Group has no CEO, or we have no data on them.


Management Age and Tenure

0.8yrs

Average Tenure

Experienced Management: A50's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.


Board Age and Tenure

1.5yrs

Average Tenure

Experienced Board: A50's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Jimmy Wong (46yo)

    Group Chief Financial Officer of TMC Life Sciences Berhad

    • Tenure: 0yrs
  • Chee Kien Seah

    Managing Director of RSP Architecture & Design

    • Tenure: 0yrs
  • Swee Chiew Beh

    Managing Director of RSP Civil & Structural Engineering

    • Tenure: 0yrs
  • Wan Binti Wan Mohd Abdullah Yaakob (34yo)

    Group CEO of TMC Life Sciences Berhad & CEO of Thomson Hospital Kota Damansara

    • Tenure: 0yrs
  • Zing Tan

    Chief Risk Officer & Director of Group Finance

    • Tenure: 0.6yrs
  • Foo Soon Soo

    Joint Secretary

    • Tenure: 1.1yrs
  • Lim Hoi Leong

    Joint Secretary

    • Tenure: 1.1yrs
  • Teo Yann

    Managing Director of Squire Mech Mechanical & Electrical Engineering

    • Tenure: 0yrs
  • Wilson Sam

    Executive Director & Group CFO

    • Tenure: 0.6yrs

Board Members

  • Ser Miang Ng (69yo)

    Non-Executive Independent Chairman

    • Tenure: 3.8yrs
  • Pang Ong (59yo)

    Independent Director

    • Tenure: 3.8yrs
  • Roy Quek

    Non-Executive Non-Independent Director

    • Tenure: 1.5yrs
  • Freddie Heng

    Non-Executive Non-Independent Director

    • Tenure: 1.5yrs
  • Wilson Sam

    Executive Director & Group CFO

    • Tenure: 0.6yrs
  • Wee Lim

    Non-Executive & Non-Independent Director

    • Tenure: 0.6yrs
  • Lee Lam

    Independent Non-Executive Director

    • Tenure: 0.4yrs

Company Information

Thomson Medical Group Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Thomson Medical Group Limited
  • Ticker: A50
  • Exchange: SGX
  • Founded: 1979
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: S$1.507b
  • Shares outstanding: 26.44b
  • Website: https://www.thomsonmedicalgroup.com

Number of Employees


Location

  • Thomson Medical Group Limited
  • 101 Thomson Road, No. 20-04/05
  • United Square
  • Singapore
  • 307591
  • Singapore

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
A50SGX (Singapore Exchange)YesOrdinary SharesSGSGDApr 2018
3H5DB (Deutsche Boerse AG)YesOrdinary SharesDEEURApr 2018

Biography

Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore, Malaysia, the United Kingdom, China, the Middle East, and internationally. Th ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/14 12:55
End of Day Share Price2019/10/14 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.